Pages that link to "Q51889942"
Jump to navigation
Jump to search
The following pages link to Trevor Hambley (Q51889942):
Displaying 50 items.
- [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes (Q33356710) (← links)
- Targeted cancer therapeutics (Q33408121) (← links)
- Intracellular trafficking as a determinant of AS-DACA cytotoxicity in rhabdomyosarcoma cells (Q34001272) (← links)
- Platinum(IV) anticancer complexes. (Q35810260) (← links)
- Copper and zinc complexes as antiinflammatory drugs. (Q35810318) (← links)
- A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo (Q36553285) (← links)
- Basis for design and development of platinum(IV) anticancer complexes (Q36865704) (← links)
- Bioreductive activation and drug chaperoning in cobalt pharmaceuticals (Q36935315) (← links)
- Developing new metal-based therapeutics: challenges and opportunities (Q36997174) (← links)
- Platinum drug distribution in cancer cells and tumors (Q37587977) (← links)
- DNA-binding and molecular mechanics modelling studies of the bulky chiral platinum(II) complex [PtCl(2)(mepyrr)] (mepyrr=N-methyl-2-aminomethylpyrrolidine). (Q38307947) (← links)
- Binding of [Pt(1C3)(dien)](2 ) to the duplex DNA oligonucleotide 5'-d(TGGCCA)-3': the effect of an appended positive charge on the orientation and location of anthraquinone intercalation (Q38357063) (← links)
- Stereospecificity and enantioselectivity in the binding of the platinum(II) complex [PtCl2(tmdz)] (tmdz = 5,5,7-trimethyl-1,4-diazacycloheptane) to dinucleotides and oligonucleotides (Q38358097) (← links)
- Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells (Q38827618) (← links)
- Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells (Q39084154) (← links)
- Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex (Q39235332) (← links)
- Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models (Q39255510) (← links)
- Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]. (Q39291500) (← links)
- Cobalt complexes with tripodal ligands: implications for the design of drug chaperones (Q39299094) (← links)
- The use of spectroscopic imaging and mapping techniques in the characterisation and study of DLD-1 cell spheroid tumour models (Q39303258) (← links)
- Structural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: the importance of pKa matching (Q39338483) (← links)
- Effects of enzymatic activation on the distribution of fluorescently tagged MMP-2 cleavable peptides in cancer cells and spheroids (Q39343619) (← links)
- Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES). (Q39351762) (← links)
- The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity (Q39645952) (← links)
- Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats (Q39758992) (← links)
- Iron(III) complexes of fluorescent hydroxamate ligands: preparation, properties, and cellular processing (Q39761118) (← links)
- Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells (Q39831466) (← links)
- Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models (Q39837102) (← links)
- Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells (Q39863011) (← links)
- Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtCl2(R-dimepyrr)] (R-dimepyrr=N-dimethyl-2(R)-aminomethylpyrrolidin (Q39888612) (← links)
- Cellular uptake and distribution of cobalt complexes of fluorescent ligands (Q39991099) (← links)
- The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines (Q40509008) (← links)
- Structural investigations of palladium(II) and platinum(II) complexes of salicylhydroxamic acid (Q43902697) (← links)
- Studies of the binding of a series of platinum(IV) complexes to plasma proteins (Q43919678) (← links)
- Preparation and cell growth inhibitory activity of [PtR(2)L(2)] (R=polyfluorophenyl, L(2)=diene, cyclohexane-1,2-diamine (chxn) or cis-(dimethyl sulfoxide)(2)) and the X-ray crystal structure of [Pt(C(6)F(5))(2)(cis-chxn)]. (Q44025756) (← links)
- Examination of the effects of oxidation and ring closure on the cytotoxicities of the platinum complexes of N-(2-hydroxyethyl)ethane-1,2-diamine and ethane-1,2-diamine-N,N'-diacetic acid (Q44066736) (← links)
- X-ray crystal structure of (eta(5)-pentaphenylcyclopentadienyl)[1-(eta(5/6)-phenyl)-2,3,4,5-tetraphenylcyclopentadienyl]iron(II), [Fe(eta(5)-C(5)Ph(5))[(eta(5/6)-C(6)H(5))C(5)Ph(4)]], a linkage isomer of decaphenylferrocene (Q44121810) (← links)
- Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin (Q44222827) (← links)
- Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin (Q44401788) (← links)
- Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum(II) analogues of AMD473. (Q44454129) (← links)
- Specificity in template syntheses of hexaaza-macrobicyclic cages: [Pt(Me5-tricosatrieneN6)]4 and [Pt(Me5-tricosaneN6)]4 . (Q44554268) (← links)
- Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design (Q44679743) (← links)
- XAFS studies of anti-inflammatory dinuclear and mononuclear Zn(II) complexes of indomethacin (Q44682195) (← links)
- Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models (Q44688008) (← links)
- X-ray absorption spectroscopic studies of chromium(V/IV/III)- 2-ethyl-2-hydroxybutanoato(2-/1-) complexes (Q44749974) (← links)
- Studies on pyridazine azide cyclisation reactions (Q44929811) (← links)
- Nuclear magnetic resonance analysis of indomethacin-induced gastric ulcers (Q45273153) (← links)
- Is anticancer drug development heading in the right direction? (Q46125870) (← links)
- Enantioselectivity and stereoselectivity in the reactions of the enantiomers of the platinum complex [PtCl2(ahaz)] (ahaz=3(R)- or 3(S)-aminohexahydroazepine) with DNA. (Q46253392) (← links)
- Fluorescent sensing of monofunctional platinum species (Q46761280) (← links)